Last update 01 Nov 2024
NeuroTau, Inc.

NeuroTau, Inc.

Startups
|
Private Company|
2017|
Tennessee, United States
|
< 10
|
neurotau.com

Overview

Tags

Other Diseases
Nervous System Diseases
Congenital Disorders
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases3
Endocrinology and Metabolic Disease2
Top 5 Drug TypeCount
Small molecule drug3
Top 5 TargetCount
GSK-3β x Sp11
COX(Cyclooxygenases)1
Sp1(Transcription factor Sp1)1

Related

3
Drugs associated with NeuroTau, Inc.
Tolfenamic Acid
Target
COX
Mechanism
COX inhibitors
Active Org.
Hangzhou Minsheng Pharmaceutical Co., Ltd.Hangzhou Minsheng Pharmaceutical Co., Ltd. [+1]
Originator Org.
Hangzhou Minsheng Pharmaceutical Co., Ltd.Hangzhou Minsheng Pharmaceutical Co., Ltd.
Active Indication
Arthritis [+3]
Inactive Indication
Supranuclear Palsy, Progressive
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CN
First Approval Date13 Jul 2005
NTX-721
Target
GSK-3β x Sp1
Mechanism
GSK-3β inhibitors [+1]
Active Org.
NeuroTau, Inc.NeuroTau, Inc.Startup
Originator Org.
NeuroTau, Inc.NeuroTau, Inc.Startup
Active Indication
Alzheimer Disease [+3]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
NTX-341
Target
Sp1
Mechanism
Sp1 inhibitors
Active Org.
NeuroTau, Inc.NeuroTau, Inc.Startup
Originator Org.
NeuroTau, Inc.NeuroTau, Inc.Startup
Active Indication
Alzheimer Disease [+3]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with NeuroTau, Inc.
NCT04253132 / Unknown statusPhase 1/2
A Phase 2a Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Tolfenamic Acid for the Treatment of Progressive Supranuclear Palsy
100 Clinical Results associated with NeuroTau, Inc.
Login to view more data
0 Patents (Medical) associated with NeuroTau, Inc.
Login to view more data
100 Deals associated with NeuroTau, Inc.
Login to view more data
100 Translational Medicine associated with NeuroTau, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
1
Phase 2 Clinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Tolfenamic Acid
 ( COX )		Frontotemporal Dementia
More
Phase 2
NTX-721
 ( GSK-3β x Sp1 )		Huntington Disease
More
Preclinical
NTX-341
 ( Sp1 )		Down Syndrome
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free